Rapid, visual, label-based biosensor platform for identification of hepatitis C virus in clinical applications

Abstract Objectives In the current study, for the first time, we reported a novel HCV molecular diagnostic approach termed reverse transcription loop-mediated isothermal amplification integrated with a gold nanoparticles-based lateral flow biosensor (RT-LAMP-AuNPs-LFB), which we developed for rapid,...

Full description

Bibliographic Details
Main Authors: Yuanfang Shi, Qingxue Zhou, Shilei Dong, Qi Zhao, Xue Wu, Peng Yang, Xiaoyan Zeng, Xinggui Yang, Yan Tan, Xinhua Luo, Zhenghua Xiao, Xu Chen
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Microbiology
Subjects:
Online Access:https://doi.org/10.1186/s12866-024-03220-9
_version_ 1797275660113149952
author Yuanfang Shi
Qingxue Zhou
Shilei Dong
Qi Zhao
Xue Wu
Peng Yang
Xiaoyan Zeng
Xinggui Yang
Yan Tan
Xinhua Luo
Zhenghua Xiao
Xu Chen
author_facet Yuanfang Shi
Qingxue Zhou
Shilei Dong
Qi Zhao
Xue Wu
Peng Yang
Xiaoyan Zeng
Xinggui Yang
Yan Tan
Xinhua Luo
Zhenghua Xiao
Xu Chen
author_sort Yuanfang Shi
collection DOAJ
description Abstract Objectives In the current study, for the first time, we reported a novel HCV molecular diagnostic approach termed reverse transcription loop-mediated isothermal amplification integrated with a gold nanoparticles-based lateral flow biosensor (RT-LAMP-AuNPs-LFB), which we developed for rapid, sensitive, specific, simple, and visual identification of HCV. Methods A set of LAMP primer was designed according to 5’untranslated region (5’UTR) gene from the major HCV genotypes 1b, 2a, 3b, 6a, and 3a, which are prevalent in China. The HCV-RT-LAMP-AuNPs-LFB assay conditions, including HCV-RT-LAMP reaction temperature and time were optimized. The sensitivity, specificity, and selectivity of our assay were evaluated in the current study. The feasibility of HCV-RT-LAMP-AuNPs-LFB was confirmed through clinical serum samples from patients with suspected HCV infections. Results An unique set of HCV-RT-LAMP primers were successfully designed targeting on the 5’UTR gene. The optimal detection process, including crude nucleic acid extraction (approximately 5 min), RT-LAMP reaction (67℃, 30 min), and visual interpretation of AuNPs-LFB results (~ 2 min), could be performed within 40 min without specific instruments. The limit of detection was determined to be 20 copies per test. The HCV-RT-LAMP-AuNPs-LFB assay exhibited high specificity and anti-interference. Conclusions These preliminary results confirmed that the HCV-RT-LAMP-AuNPs-LFB assay is a sensitive, specific, rapid, visual, and cost-saving assay for identification of HCV. This diagnostic approach has great potential value for point-of-care (POC) diagnostic of HCV, especially in resource-challenged regions.
first_indexed 2024-03-07T15:16:41Z
format Article
id doaj.art-07ec3aa817204459858d834cc365e78e
institution Directory Open Access Journal
issn 1471-2180
language English
last_indexed 2024-03-07T15:16:41Z
publishDate 2024-02-01
publisher BMC
record_format Article
series BMC Microbiology
spelling doaj.art-07ec3aa817204459858d834cc365e78e2024-03-05T17:51:32ZengBMCBMC Microbiology1471-21802024-02-0124111310.1186/s12866-024-03220-9Rapid, visual, label-based biosensor platform for identification of hepatitis C virus in clinical applicationsYuanfang Shi0Qingxue Zhou1Shilei Dong2Qi Zhao3Xue Wu4Peng Yang5Xiaoyan Zeng6Xinggui Yang7Yan Tan8Xinhua Luo9Zhenghua Xiao10Xu Chen11The Second Clinical Medical College, Guizhou University of Traditional Chinese MedicineClinical Laboratory, Hangzhou Women’s HospitalDepartment of Clinical Laboratory, Zhejiang HospitalDepartment of gastroenterology, the Second Affiliated Hospital, Guizhou University of Traditional Chinese MedicineDepartment of Scientific Research, the Second Affiliated Hospital, Guizhou University of Traditional Chinese MedicineClinical Laboratory, the Second Affiliated Hospital, Guizhou University of Traditional Chinese MedicineCentral Laboratory of the Second Affiliated Hospital, Guizhou University of Traditional Chinese MedicineExperiment Center, Guizhou Provincial Centre for Disease Control and PreventionClinical Laboratory, Guizhou Provincial Center for Clinical LaboratoryDepartment of Infectious Disease, Guizhou Provincial People’s HospitalThe Second Clinical Medical College, Guizhou University of Traditional Chinese MedicineThe Second Clinical Medical College, Guizhou University of Traditional Chinese MedicineAbstract Objectives In the current study, for the first time, we reported a novel HCV molecular diagnostic approach termed reverse transcription loop-mediated isothermal amplification integrated with a gold nanoparticles-based lateral flow biosensor (RT-LAMP-AuNPs-LFB), which we developed for rapid, sensitive, specific, simple, and visual identification of HCV. Methods A set of LAMP primer was designed according to 5’untranslated region (5’UTR) gene from the major HCV genotypes 1b, 2a, 3b, 6a, and 3a, which are prevalent in China. The HCV-RT-LAMP-AuNPs-LFB assay conditions, including HCV-RT-LAMP reaction temperature and time were optimized. The sensitivity, specificity, and selectivity of our assay were evaluated in the current study. The feasibility of HCV-RT-LAMP-AuNPs-LFB was confirmed through clinical serum samples from patients with suspected HCV infections. Results An unique set of HCV-RT-LAMP primers were successfully designed targeting on the 5’UTR gene. The optimal detection process, including crude nucleic acid extraction (approximately 5 min), RT-LAMP reaction (67℃, 30 min), and visual interpretation of AuNPs-LFB results (~ 2 min), could be performed within 40 min without specific instruments. The limit of detection was determined to be 20 copies per test. The HCV-RT-LAMP-AuNPs-LFB assay exhibited high specificity and anti-interference. Conclusions These preliminary results confirmed that the HCV-RT-LAMP-AuNPs-LFB assay is a sensitive, specific, rapid, visual, and cost-saving assay for identification of HCV. This diagnostic approach has great potential value for point-of-care (POC) diagnostic of HCV, especially in resource-challenged regions.https://doi.org/10.1186/s12866-024-03220-9Hepatitis C virusReverse transcription loop-mediated isothermal amplificationBiosensorPoint-of-care platformLimit of detection
spellingShingle Yuanfang Shi
Qingxue Zhou
Shilei Dong
Qi Zhao
Xue Wu
Peng Yang
Xiaoyan Zeng
Xinggui Yang
Yan Tan
Xinhua Luo
Zhenghua Xiao
Xu Chen
Rapid, visual, label-based biosensor platform for identification of hepatitis C virus in clinical applications
BMC Microbiology
Hepatitis C virus
Reverse transcription loop-mediated isothermal amplification
Biosensor
Point-of-care platform
Limit of detection
title Rapid, visual, label-based biosensor platform for identification of hepatitis C virus in clinical applications
title_full Rapid, visual, label-based biosensor platform for identification of hepatitis C virus in clinical applications
title_fullStr Rapid, visual, label-based biosensor platform for identification of hepatitis C virus in clinical applications
title_full_unstemmed Rapid, visual, label-based biosensor platform for identification of hepatitis C virus in clinical applications
title_short Rapid, visual, label-based biosensor platform for identification of hepatitis C virus in clinical applications
title_sort rapid visual label based biosensor platform for identification of hepatitis c virus in clinical applications
topic Hepatitis C virus
Reverse transcription loop-mediated isothermal amplification
Biosensor
Point-of-care platform
Limit of detection
url https://doi.org/10.1186/s12866-024-03220-9
work_keys_str_mv AT yuanfangshi rapidvisuallabelbasedbiosensorplatformforidentificationofhepatitiscvirusinclinicalapplications
AT qingxuezhou rapidvisuallabelbasedbiosensorplatformforidentificationofhepatitiscvirusinclinicalapplications
AT shileidong rapidvisuallabelbasedbiosensorplatformforidentificationofhepatitiscvirusinclinicalapplications
AT qizhao rapidvisuallabelbasedbiosensorplatformforidentificationofhepatitiscvirusinclinicalapplications
AT xuewu rapidvisuallabelbasedbiosensorplatformforidentificationofhepatitiscvirusinclinicalapplications
AT pengyang rapidvisuallabelbasedbiosensorplatformforidentificationofhepatitiscvirusinclinicalapplications
AT xiaoyanzeng rapidvisuallabelbasedbiosensorplatformforidentificationofhepatitiscvirusinclinicalapplications
AT xingguiyang rapidvisuallabelbasedbiosensorplatformforidentificationofhepatitiscvirusinclinicalapplications
AT yantan rapidvisuallabelbasedbiosensorplatformforidentificationofhepatitiscvirusinclinicalapplications
AT xinhualuo rapidvisuallabelbasedbiosensorplatformforidentificationofhepatitiscvirusinclinicalapplications
AT zhenghuaxiao rapidvisuallabelbasedbiosensorplatformforidentificationofhepatitiscvirusinclinicalapplications
AT xuchen rapidvisuallabelbasedbiosensorplatformforidentificationofhepatitiscvirusinclinicalapplications